MRI brain test to predict prostate cancer risk
Part of Cancer, Kidney & urinary clinical trials.
This study uses MRI scans and artificial intelligence to predict the risk of clinically significant prostate cancer. It may help find a way to detect aggressive cancers without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an MRI of your prostate within 3 months of your biopsy.
- Your medical records from the MRI and biopsy are complete and available.
- You have not had any treatment for prostate cancer before the MRI or biopsy.
- You have not had surgery or taken finasteride or dutasteride for an enlarged prostate.
- You did not have a urinary catheter in place during your MRI.
- Your MRI images are clear enough for analysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This trial tests a computer model that learns from MRI scans to predict prostate cancer. If you have had a prostate MRI showing suspicious areas and are scheduled for a biopsy, joining may help improve how cancer is detected.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.